Medication Adherence and Non-adherence in Adults With Rare Disease
- Status
- WITHDRAWN
- Phase
- N/A
Clinical Trials Related to Idiopathic Pulmonary Fibrosis
Related studies linked through entity extraction aliases.
A Phase 1 Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Immunogenicity of HuL001
- Status
- COMPLETED
- Phase
- PHASE1
Safety, Efficacy and Pharmacokinetics of C21 in Subjects With IPF
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Effectiveness of Nintedanib in Korean Patients
- Status
- COMPLETED
- Phase
- N/A
Single and Multiple Dose Safety, Tolerability, PK and Food Effect Study of HEC585 in Healthy Male and Female Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Development of Airway Absorption Sampling Methods
- Status
- WITHDRAWN
- Phase
- N/A
Inspiratory Muscle Training in Patients With Interstitial Lung Disease
- Status
- COMPLETED
- Phase
- NA
Cohort of IPF Patients Experiencing an Exacerbation
- Status
- RECRUITING
- Phase
- N/A
To Evaluate the Use of Radiomics to Classify Between Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease
- Status
- COMPLETED
- Phase
- N/A
Morphine Sulfate/Placebo for the Treatment of PulmonAry Fibrosis Cough
- Status
- COMPLETED
- Phase
- PHASE3
Zephyrus II: Efficacy and Safety Study of Pamrevlumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
- Status
- TERMINATED
- Phase
- PHASE3
A Study to Test How Taking BI 1015550 for 12 Weeks Affects Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF)
- Status
- COMPLETED
- Phase
- PHASE2
Evaluation of Efficacy and Safety of PLN-74809 in Patients With Idiopathic Pulmonary Fibrosis
- Status
- COMPLETED
- Phase
- PHASE2
Molecular Imaging Probes to Inform Heterogeneity in Idiopathic Pulmonary Fibrosis
- Status
- RECRUITING
- Phase
- PHASE1
Use of cSVF Via IV Deployment for Residual Lung Damage After Symptomatic COVID-19 Infection
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
Efficacy, Safety and Tolerability of NP-120 on Idiopathic Pulmonary Fibrosis and Its Associated Cough
- Status
- COMPLETED
- Phase
- PHASE2
Impact of Pre-transplant Anti-fibrotic Therapy for IPF Upon Lung Transplant Outcomes
- Status
- COMPLETED
- Phase
- N/A
Study of Jaktinib Hydrochloride Tablets in Participants With Idiopathic Pulmonary Fibrosis
- Status
- COMPLETED
- Phase
- PHASE2
Prospective Treatment Efficacy in IPF Using Genotype for Nac Selection (PRECISIONS) Trial
- Status
- COMPLETED
- Phase
- PHASE3
Longitudinal Changes in Serum KL-6 in IPF
- Status
- UNKNOWN
- Phase
- N/A